A list of downloadable documents created during development.

For further information on the guideline development process, please see how we develop NICE guidelines ...

Suggested remit: To appraise the clinical and cost effectiveness of vutrisiran within its marketing authorisation for treating transthyretin amyloidosis with cardiomyopathy ...

Empagliflozin for treating type 2 diabetes in people 10 to 17 years (terminated appraisal) TA1006 12 September 2024 12 September 2024 Evinacumab for treating homozygous familial hypercholesterolaemia ...

This licence allows individuals, commercial organisations and non-commercial organisations to reuse NICE content free of charge in their publications, products and systems. It applies to requests to ...

NICE Pathways offer an easy-to-use, intuitive way of accessing our clinical, public health and social care information. They include up to date NICE guidance, quality standards and related information ...